James is the Vice President of Bioprocessing & Applications at MicrofluidX, where they are developing the Cyto Engine, a cell therapy bioprocessing and manufacturing platform. James has experience in cell and gene therapy process development and manufacturing optimisation. His work has focused on understanding the translational requirements for robust product realisation, considering aspects such as process development, manufacturability and ultimately the clinical adoption and health economic implications. He holds a Ph.D. in regenerative medicine from the Centre of Biological Engineering at Loughborough University, UK and is a awardee of the Royal Academy of Engineering’s Shott Scale Up Accelerator Award.